This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Corixa Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: D Scott Snyder: Innovator in Lipopolysaccharide Extraction
Introduction
D Scott Snyder is a notable inventor based in Hamilton, Montana. He has made significant contributions to the field of biochemistry, particularly in the extraction of lipopolysaccharides from bacterial cells. His innovative methods have implications for vaccine development and immunology.
Latest Patents
D Scott Snyder holds a patent for "Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A (3D-MLA)." This invention relates to a method for extracting lipopolysaccharide (LPS) from rough trough mutant bacteria cells. The process involves using an aqueous aliphatic alcohol with 1 to 4 carbon atoms at temperatures between 35 and 65 degrees Celsius. This method results in cells with reduced phospholipid content, which are then extracted with chloroform/methanol to yield LPS.
Career Highlights
Snyder is associated with Corixa Corporation, where he has applied his expertise in biochemistry to advance research and development. His work has been instrumental in enhancing the understanding of lipopolysaccharides and their applications in medical science.
Collaborations
One of his notable coworkers is Kent Raymond Myers, with whom he has likely collaborated on various projects within the company.
Conclusion
D Scott Snyder's innovative methods for extracting lipopolysaccharides represent a significant advancement in biochemistry. His contributions continue to influence the field and pave the way for future research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile